Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

High-Sensitivity Troponins Turned All Events into Infarctions; the 4th Universal Definition Clarifies Things

Myocardial infarction or myocardial injury? The Fourth Universal Definition of Myocardial Infarction (an update of the 2012 version) is here to clarify that not all cases of elevated cardiac troponin values are acute myocardial infarctions.

Sorpresivo pronóstico para los infartos con coronarias normalesThis document was presented a few days ago at the European Society of Cardiology (ESC) Congress in Munich and simultaneously published in Eur Heart J.

 

This is the first update since the 2012 definition, and the authors were a group of experts from the ESC, the American Heart Association (AHA), the American College of Cardiology (ACC), and the World Heart Foundation (WHF). This update establishes an explicit difference between acute myocardial infarction (which requires a rise in markers and evidence of ischemia) and myocardial injury, which features a rise in biomarkers with no ischemic cause.


Read also: ESC 2018 | CLARIFY: No Survival Benefit with Beta-Blockers Beyond 1 Year After Infarction.


A non-ischemic rise in markers can be caused by heart failure, myocarditis, catheter ablation, cardiac contusion, sepsis, chronic kidney disease, or even strenuous exercise. Much effort was put into the clarification of the difference between non-ischemic myocardial injury and acute myocardial infarction in this document.

 

The original 2007 classification of acute myocardial infarction identified 5 types. This new version opens a debate regarding different subtypes and provides figures and flow charts to assist in the diagnosis of myocardial infarction and injury.

 

The impact of this universal definition has to do with the fact that many patients are classified as undergoing acute myocardial infarction when, in fact, they only present a slight troponin elevation. On the other hand, certain slight rises in troponin values that actually derive from ischemic causes are underestimated and left to the natural disease progression, with the incorrect interpretation that everything is fine.


Read also: Cardiovascular Events During World Cup Soccer, an Old Article Worth Remembering.


These guidelines are a mere piece in this puzzle that turns medicine into a more standardized discipline than it was 50 years ago. In any case, we should remember that physicians stand between guidelines and patients, and the physicians who write these documents and those who interpret them must keep using their good clinical judgment while treating patients. No clinical practice guideline, regardless of its comprehensiveness and clarity, will turn physicians into decision-making automatons.

 

Original title: Fourth Universal Definition of Myocardial Infarction (2018).

Reference: Thygesen K et al. Eur Heart J. 2018; Epub ahead of print.

 

2018-09-19-ehy462-abierto


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...